Development of HSV-specific CD4+ Th1 responses and CD8+ cytotoxic T lymphocytes with antiviral activity by vaccination with the HSV-2 mutant ICP10ΔPK

This publication has 65 references indexed in Scilit:

• HSP22, a New Member of the Small Heat Shock Protein Superfamily, Interacts with Mimic of Phosphorylated HSP27 (3DHSP27)
  Journal of Biological Chemistry, 2001
• A growth and latency compromised herpes simplex virus type 2 mutant (ICP10ΔPK) has prophylactic and therapeutic protective activity in guinea pigs
  Vaccine, 2001
• CTL priming by CD8+ and CD8– dendritic cellsin vivo
  European Journal of Immunology, 1999
• Herpes Simplex Virus Associated Erythema Multiforme (HAEM) is Mechanistically Distinct from Drug-Induced Erythema Multiforme: Interferon-γ is Expressed in HAEM Lesions and Tumor Necrosis Factor-α in Drug-Induced Erythema Multiforme Lesions
  Journal of Investigative Dermatology, 1999
• Vaccine potential of a herpes simplex virus type 2 mutant deleted in the PK domain of the large subunit of ribonucleotide reductase (ICP10)
  Vaccine, 1999
• Effect of interleukin‐10 on dendritic cell maturation and function
  European Journal of Immunology, 1997
• A Genetically Inactivated Herpes Simplex Virus Type 2 (HSV-2) Vaccine Provides Effective Protection against Primary and Recurrent HSV-2 Disease
  The Journal of Infectious Diseases, 1997
• A Recombinant Vaccinia Virus Expressing Herpes Simplex Virus Type 1 Glycoprotein B Induces Cytotoxic T Lymphocytes in Mice
  Journal of General Virology, 1988
• Herpes Simplex Virus Glycoprotein Treatment of Recurrent Genital Herpes
  The Journal of Infectious Diseases, 1988
• Immunity to Herpes Simplex Virus: Virus Reactivation Modulates Lymphokine Activity
  The Journal of Infectious Diseases, 1985